APO Research
Talk to an analyst

APO RESEARCH · REPORT

Injectable Drug Packaging

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Injectable Drug Packaging Market Outlook and Growth Opportunities 2026

28 December 2025194 pages

Choose your research edition.

Industry ResearchInjectable Drug Packaging Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Injectable Drug Packaging Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Injectable Drug Packaging Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Injectable Drug Packaging Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Injectable Drug Packaging Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Injectable Drug Packaging market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Injectable Drug Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Injectable Drug Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Injectable Drug Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Injectable Drug Packaging market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Injectable Drug Packaging market include Becton,Dickinson and Company (U.S.), Pfizer Inc. (U.S.), Teva Pharmaceuticals Industries Ltd. (Israel), Eli Lilly and Company (U.S.), Baxter International, Inc. (U.S.), Schott AG (Germany), Gerresheimer (Germany), Ypsomed (Switzerland) and B. Braun Melsungen (Germany), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Injectable Drug Packaging market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Injectable Drug Packaging and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Injectable Drug Packaging sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Injectable Drug Packaging market size, projected growth trends, production technologies, key applications, and end-use industries.

Injectable Drug Packaging Segment by Company

Becton,Dickinson and Company (U.S.)

Pfizer Inc. (U.S.)

Teva Pharmaceuticals Industries Ltd. (Israel)

Eli Lilly and Company (U.S.)

Baxter International, Inc. (U.S.)

Schott AG (Germany)

Gerresheimer (Germany)

Ypsomed (Switzerland)

B. Braun Melsungen (Germany)

Injectable Drug Packaging Segment by Type

Ampules

Vials

Cartridges

Bottles

Injectable Drug Packaging Segment by Application

Hospitals & Clinics

Home Care Settings

Other Facilities of Use

Injectable Drug Packaging Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Injectable Drug Packaging status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Injectable Drug Packaging market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Injectable Drug Packaging significant trends, drivers, influence factors in global and regions.

6. To analyze Injectable Drug Packaging competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Injectable Drug Packaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Injectable Drug Packaging and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Injectable Drug Packaging.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Injectable Drug Packaging market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Injectable Drug Packaging industry.

Chapter 3: Detailed analysis of Injectable Drug Packaging manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Injectable Drug Packaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Injectable Drug Packaging in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Injectable Drug Packaging Industry Trends Table 2. Injectable Drug Packaging Industry Drivers Table 3. Injectable Drug Packaging Industry Opportunities and Challenges Table 4. Injectable Drug Packaging Industry Restraints Table 5. Global Injectable Drug Packaging Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Injectable Drug Packaging Revenue Share by Company (2021-2026) Table 7. Global Injectable Drug Packaging Sales Volume by Company (k units) & (2021-2026) Table 8. Global Injectable Drug Packaging Sales Volume Share by Company (2021-2026) Table 9. Global Injectable Drug Packaging Average Price (USD/unit) of Company (2021-2026) Table 10. Global Injectable Drug Packaging Company Ranking, (2024-2026) & (USD Million) Table 11. Global Injectable Drug Packaging Key Company Manufacturing Base & Headquarters Table 12. Global Injectable Drug Packaging Company, Product Type & Application Table 13. Global Injectable Drug Packaging Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Injectable Drug Packaging by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Ampules Table 18. Significant Companies of Vials Table 19. Significant Companies of Cartridges Table 20. Significant Companies of Bottles Table 21. Global Injectable Drug Packaging Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Injectable Drug Packaging Sales Volume by Type (2021-2026) & (k units) Table 23. Global Injectable Drug Packaging Sales Volume by Type (2027-2032) & (k units) Table 24. Global Injectable Drug Packaging Sales Volume Share by Type (2021-2026) Table 25. Global Injectable Drug Packaging Sales Volume Share by Type (2027-2032) Table 26. Global Injectable Drug Packaging Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Injectable Drug Packaging Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Injectable Drug Packaging Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Injectable Drug Packaging Sales Value Share by Type (2021-2026) Table 30. Global Injectable Drug Packaging Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Hospitals & Clinics Table 32. Significant Companies of Home Care Settings Table 33. Significant Companies of Other Facilities of Use Table 34. Global Injectable Drug Packaging Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Injectable Drug Packaging Sales Volume by Application (2021-2026) & (k units) Table 36. Global Injectable Drug Packaging Sales Volume by Application (2027-2032) & (k units) Table 37. Global Injectable Drug Packaging Sales Volume Share by Application (2021-2026) Table 38. Global Injectable Drug Packaging Sales Volume Share by Application (2027-2032) Table 39. Global Injectable Drug Packaging Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Injectable Drug Packaging Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Injectable Drug Packaging Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Injectable Drug Packaging Sales Value Share by Application (2021-2026) Table 43. Global Injectable Drug Packaging Sales Value Share by Application (2027-2032) Table 44. Global Injectable Drug Packaging Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Injectable Drug Packaging Sales by Region (2021-2026) & (k units) Table 46. Global Injectable Drug Packaging Sales Market Share by Region (2021-2026) Table 47. Global Injectable Drug Packaging Sales by Region (2027-2032) & (k units) Table 48. Global Injectable Drug Packaging Sales Market Share by Region (2027-2032) Table 49. Global Injectable Drug Packaging Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Injectable Drug Packaging Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Injectable Drug Packaging Sales Value Share by Region (2021-2026) Table 52. Global Injectable Drug Packaging Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Injectable Drug Packaging Sales Value Share by Region (2027-2032) Table 54. Global Injectable Drug Packaging Market Average Price (USD/unit) by Region (2021-2026) Table 55. Global Injectable Drug Packaging Market Average Price (USD/unit) by Region (2027-2032) Table 56. Global Injectable Drug Packaging Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Global Injectable Drug Packaging Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Injectable Drug Packaging Sales by Country (2021-2026) & (k units) Table 59. Global Injectable Drug Packaging Sales Market Share by Country (2021-2026) Table 60. Global Injectable Drug Packaging Sales by Country (2027-2032) & (k units) Table 61. Global Injectable Drug Packaging Sales Market Share by Country (2027-2032) Table 62. Global Injectable Drug Packaging Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Injectable Drug Packaging Sales Value Market Share by Country (2021-2026) Table 64. Global Injectable Drug Packaging Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Injectable Drug Packaging Sales Value Market Share by Country (2027-2032) Table 66. Becton,Dickinson and Company (U.S.) Company Information Table 67. Becton,Dickinson and Company (U.S.) Business Overview Table 68. Becton,Dickinson and Company (U.S.) Injectable Drug Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 69. Becton,Dickinson and Company (U.S.) Injectable Drug Packaging Product Portfolio Table 70. Becton,Dickinson and Company (U.S.) Recent Development Table 71. Pfizer Inc. (U.S.) Company Information Table 72. Pfizer Inc. (U.S.) Business Overview Table 73. Pfizer Inc. (U.S.) Injectable Drug Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. Pfizer Inc. (U.S.) Injectable Drug Packaging Product Portfolio Table 75. Pfizer Inc. (U.S.) Recent Development Table 76. Teva Pharmaceuticals Industries Ltd. (Israel) Company Information Table 77. Teva Pharmaceuticals Industries Ltd. (Israel) Business Overview Table 78. Teva Pharmaceuticals Industries Ltd. (Israel) Injectable Drug Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. Teva Pharmaceuticals Industries Ltd. (Israel) Injectable Drug Packaging Product Portfolio Table 80. Teva Pharmaceuticals Industries Ltd. (Israel) Recent Development Table 81. Eli Lilly and Company (U.S.) Company Information Table 82. Eli Lilly and Company (U.S.) Business Overview Table 83. Eli Lilly and Company (U.S.) Injectable Drug Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. Eli Lilly and Company (U.S.) Injectable Drug Packaging Product Portfolio Table 85. Eli Lilly and Company (U.S.) Recent Development Table 86. Baxter International, Inc. (U.S.) Company Information Table 87. Baxter International, Inc. (U.S.) Business Overview Table 88. Baxter International, Inc. (U.S.) Injectable Drug Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Baxter International, Inc. (U.S.) Injectable Drug Packaging Product Portfolio Table 90. Baxter International, Inc. (U.S.) Recent Development Table 91. Schott AG (Germany) Company Information Table 92. Schott AG (Germany) Business Overview Table 93. Schott AG (Germany) Injectable Drug Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Schott AG (Germany) Injectable Drug Packaging Product Portfolio Table 95. Schott AG (Germany) Recent Development Table 96. Gerresheimer (Germany) Company Information Table 97. Gerresheimer (Germany) Business Overview Table 98. Gerresheimer (Germany) Injectable Drug Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Gerresheimer (Germany) Injectable Drug Packaging Product Portfolio Table 100. Gerresheimer (Germany) Recent Development Table 101. Ypsomed (Switzerland) Company Information Table 102. Ypsomed (Switzerland) Business Overview Table 103. Ypsomed (Switzerland) Injectable Drug Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Ypsomed (Switzerland) Injectable Drug Packaging Product Portfolio Table 105. Ypsomed (Switzerland) Recent Development Table 106. B. Braun Melsungen (Germany) Company Information Table 107. B. Braun Melsungen (Germany) Business Overview Table 108. B. Braun Melsungen (Germany) Injectable Drug Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. B. Braun Melsungen (Germany) Injectable Drug Packaging Product Portfolio Table 110. B. Braun Melsungen (Germany) Recent Development Table 111. Key Raw Materials Table 112. Raw Materials Key Suppliers Table 113. Injectable Drug Packaging Distributors List Table 114. Injectable Drug Packaging Customers List Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Injectable Drug Packaging Product Image Figure 2. Global Injectable Drug Packaging Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Injectable Drug Packaging Sales Value (2021-2032) & (US$ Million) Figure 4. Global Injectable Drug Packaging Sales (2021-2032) & (k units) Figure 5. Global Injectable Drug Packaging Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Injectable Drug Packaging Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Ampules Image Figure 10. Vials Image Figure 11. Cartridges Image Figure 12. Bottles Image Figure 13. Global Injectable Drug Packaging Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Injectable Drug Packaging Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Injectable Drug Packaging Sales Volume Share by Type (2021-2032) Figure 16. Global Injectable Drug Packaging Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Injectable Drug Packaging Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Injectable Drug Packaging Sales Value Share by Type (2021-2032) Figure 19. Hospitals & Clinics Image Figure 20. Home Care Settings Image Figure 21. Other Facilities of Use Image Figure 22. Global Injectable Drug Packaging Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Injectable Drug Packaging Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Injectable Drug Packaging Sales Volume Share by Application (2021-2032) Figure 25. Global Injectable Drug Packaging Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Injectable Drug Packaging Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Injectable Drug Packaging Sales Value Share by Application (2021-2032) Figure 28. Global Injectable Drug Packaging Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 29. Global Injectable Drug Packaging Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Injectable Drug Packaging Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Injectable Drug Packaging Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Injectable Drug Packaging Sales Value (2021-2032) & (US$ Million) Figure 33. North America Injectable Drug Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Injectable Drug Packaging Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Injectable Drug Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Injectable Drug Packaging Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Injectable Drug Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Injectable Drug Packaging Sales Value (2021-2032) & (US$ Million) Figure 39. South America Injectable Drug Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Injectable Drug Packaging Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Injectable Drug Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Injectable Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Injectable Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Injectable Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Injectable Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Injectable Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Injectable Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Injectable Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Injectable Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Injectable Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Injectable Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Injectable Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Injectable Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Injectable Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Injectable Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Injectable Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Injectable Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Injectable Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Injectable Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Injectable Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Injectable Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Injectable Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Injectable Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Injectable Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Injectable Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Injectable Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Injectable Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Injectable Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Injectable Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Injectable Drug Packaging Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Injectable Drug Packaging Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Ampules
  • Vials
  • Cartridges
  • Bottles
Applications
  • Hospitals & Clinics
  • Home Care Settings
  • Other Facilities of Use
Companies covered
  • Becton,Dickinson and Company (U.S.)
  • Pfizer Inc. (U.S.)
  • Teva Pharmaceuticals Industries Ltd. (Israel)
  • Eli Lilly and Company (U.S.)
  • Baxter International, Inc. (U.S.)
  • Schott AG (Germany)
  • Gerresheimer (Germany)
  • Ypsomed (Switzerland)
  • B. Braun Melsungen (Germany)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Injectable Drug Packaging Sales Value (2021-2032)
  4. 1.2.2 Global Injectable Drug Packaging Sales Volume (2021-2032)
  5. 1.2.3 Global Injectable Drug Packaging Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Injectable Drug Packaging Market Dynamics
  1. 2.1 Injectable Drug Packaging Industry Trends
  2. 2.2 Injectable Drug Packaging Industry Drivers
  3. 2.3 Injectable Drug Packaging Industry Opportunities and Challenges
  4. 2.4 Injectable Drug Packaging Industry Restraints
3 Injectable Drug Packaging Market by Company
  1. 3.1 Global Injectable Drug Packaging Company Revenue Ranking in 2025
  2. 3.2 Global Injectable Drug Packaging Revenue by Company (2021-2026)
  3. 3.3 Global Injectable Drug Packaging Sales Volume by Company (2021-2026)
  4. 3.4 Global Injectable Drug Packaging Average Price by Company (2021-2026)
  5. 3.5 Global Injectable Drug Packaging Company Ranking (2024-2026)
  6. 3.6 Global Injectable Drug Packaging Company Manufacturing Base and Headquarters
  7. 3.7 Global Injectable Drug Packaging Company Product Type and Application
  8. 3.8 Global Injectable Drug Packaging Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Injectable Drug Packaging Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Injectable Drug Packaging Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Injectable Drug Packaging Market by Type
  1. 4.1 Injectable Drug Packaging Type Introduction
  2. 4.1.1 Ampules
  3. 4.1.2 Vials
  4. 4.1.3 Cartridges
  5. 4.1.4 Bottles
  6. 4.2 Global Injectable Drug Packaging Sales Volume by Type
  7. 4.2.1 Global Injectable Drug Packaging Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Injectable Drug Packaging Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Injectable Drug Packaging Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Injectable Drug Packaging Sales Value by Type
  11. 4.3.1 Global Injectable Drug Packaging Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Injectable Drug Packaging Sales Value by Type (2021-2032)
  13. 4.3.3 Global Injectable Drug Packaging Sales Value Share by Type (2021-2032)
5 Injectable Drug Packaging Market by Application
  1. 5.1 Injectable Drug Packaging Application Introduction
  2. 5.1.1 Hospitals & Clinics
  3. 5.1.2 Home Care Settings
  4. 5.1.3 Other Facilities of Use
  5. 5.2 Global Injectable Drug Packaging Sales Volume by Application
  6. 5.2.1 Global Injectable Drug Packaging Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Injectable Drug Packaging Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Injectable Drug Packaging Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Injectable Drug Packaging Sales Value by Application
  10. 5.3.1 Global Injectable Drug Packaging Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Injectable Drug Packaging Sales Value by Application (2021-2032)
  12. 5.3.3 Global Injectable Drug Packaging Sales Value Share by Application (2021-2032)
6 Injectable Drug Packaging Regional Sales and Value Analysis
  1. 6.1 Global Injectable Drug Packaging Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Injectable Drug Packaging Sales by Region (2021-2032)
  3. 6.2.1 Global Injectable Drug Packaging Sales by Region: 2021-2026
  4. 6.2.2 Global Injectable Drug Packaging Sales by Region (2027-2032)
  5. 6.3 Global Injectable Drug Packaging Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Injectable Drug Packaging Sales Value by Region (2021-2032)
  7. 6.4.1 Global Injectable Drug Packaging Sales Value by Region: 2021-2026
  8. 6.4.2 Global Injectable Drug Packaging Sales Value by Region (2027-2032)
  9. 6.5 Global Injectable Drug Packaging Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Injectable Drug Packaging Sales Value (2021-2032)
  12. 6.6.2 North America Injectable Drug Packaging Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Injectable Drug Packaging Sales Value (2021-2032)
  15. 6.7.2 Europe Injectable Drug Packaging Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Injectable Drug Packaging Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Injectable Drug Packaging Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Injectable Drug Packaging Sales Value (2021-2032)
  21. 6.9.2 South America Injectable Drug Packaging Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Injectable Drug Packaging Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Injectable Drug Packaging Sales Value Share by Country, 2025 VS 2032
7 Injectable Drug Packaging Country-level Sales and Value Analysis
  1. 7.1 Global Injectable Drug Packaging Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Injectable Drug Packaging Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Injectable Drug Packaging Sales by Country (2021-2032)
  4. 7.3.1 Global Injectable Drug Packaging Sales by Country (2021-2026)
  5. 7.3.2 Global Injectable Drug Packaging Sales by Country (2027-2032)
  6. 7.4 Global Injectable Drug Packaging Sales Value by Country (2021-2032)
  7. 7.4.1 Global Injectable Drug Packaging Sales Value by Country (2021-2026)
  8. 7.4.2 Global Injectable Drug Packaging Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Injectable Drug Packaging Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Injectable Drug Packaging Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Injectable Drug Packaging Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Injectable Drug Packaging Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Injectable Drug Packaging Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Injectable Drug Packaging Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Injectable Drug Packaging Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Injectable Drug Packaging Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Injectable Drug Packaging Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Injectable Drug Packaging Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Injectable Drug Packaging Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Injectable Drug Packaging Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Injectable Drug Packaging Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Injectable Drug Packaging Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Injectable Drug Packaging Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Injectable Drug Packaging Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Injectable Drug Packaging Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Injectable Drug Packaging Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Injectable Drug Packaging Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Injectable Drug Packaging Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Injectable Drug Packaging Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Injectable Drug Packaging Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Injectable Drug Packaging Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Injectable Drug Packaging Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Injectable Drug Packaging Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Injectable Drug Packaging Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Injectable Drug Packaging Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Injectable Drug Packaging Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Injectable Drug Packaging Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Injectable Drug Packaging Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Becton,Dickinson and Company (U.S.)
  2. 8.1.1 Becton,Dickinson and Company (U.S.) Company Information
  3. 8.1.2 Becton,Dickinson and Company (U.S.) Business Overview
  4. 8.1.3 Becton,Dickinson and Company (U.S.) Injectable Drug Packaging Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Becton,Dickinson and Company (U.S.) Injectable Drug Packaging Product Portfolio
  6. 8.1.5 Becton,Dickinson and Company (U.S.) Recent Developments
  7. 8.2 Pfizer Inc. (U.S.)
  8. 8.2.1 Pfizer Inc. (U.S.) Company Information
  9. 8.2.2 Pfizer Inc. (U.S.) Business Overview
  10. 8.2.3 Pfizer Inc. (U.S.) Injectable Drug Packaging Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Inc. (U.S.) Injectable Drug Packaging Product Portfolio
  12. 8.2.5 Pfizer Inc. (U.S.) Recent Developments
  13. 8.3 Teva Pharmaceuticals Industries Ltd. (Israel)
  14. 8.3.1 Teva Pharmaceuticals Industries Ltd. (Israel) Company Information
  15. 8.3.2 Teva Pharmaceuticals Industries Ltd. (Israel) Business Overview
  16. 8.3.3 Teva Pharmaceuticals Industries Ltd. (Israel) Injectable Drug Packaging Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Teva Pharmaceuticals Industries Ltd. (Israel) Injectable Drug Packaging Product Portfolio
  18. 8.3.5 Teva Pharmaceuticals Industries Ltd. (Israel) Recent Developments
  19. 8.4 Eli Lilly and Company (U.S.)
  20. 8.4.1 Eli Lilly and Company (U.S.) Company Information
  21. 8.4.2 Eli Lilly and Company (U.S.) Business Overview
  22. 8.4.3 Eli Lilly and Company (U.S.) Injectable Drug Packaging Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Eli Lilly and Company (U.S.) Injectable Drug Packaging Product Portfolio
  24. 8.4.5 Eli Lilly and Company (U.S.) Recent Developments
  25. 8.5 Baxter International, Inc. (U.S.)
  26. 8.5.1 Baxter International, Inc. (U.S.) Company Information
  27. 8.5.2 Baxter International, Inc. (U.S.) Business Overview
  28. 8.5.3 Baxter International, Inc. (U.S.) Injectable Drug Packaging Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Baxter International, Inc. (U.S.) Injectable Drug Packaging Product Portfolio
  30. 8.5.5 Baxter International, Inc. (U.S.) Recent Developments
  31. 8.6 Schott AG (Germany)
  32. 8.6.1 Schott AG (Germany) Company Information
  33. 8.6.2 Schott AG (Germany) Business Overview
  34. 8.6.3 Schott AG (Germany) Injectable Drug Packaging Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Schott AG (Germany) Injectable Drug Packaging Product Portfolio
  36. 8.6.5 Schott AG (Germany) Recent Developments
  37. 8.7 Gerresheimer (Germany)
  38. 8.7.1 Gerresheimer (Germany) Company Information
  39. 8.7.2 Gerresheimer (Germany) Business Overview
  40. 8.7.3 Gerresheimer (Germany) Injectable Drug Packaging Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Gerresheimer (Germany) Injectable Drug Packaging Product Portfolio
  42. 8.7.5 Gerresheimer (Germany) Recent Developments
  43. 8.8 Ypsomed (Switzerland)
  44. 8.8.1 Ypsomed (Switzerland) Company Information
  45. 8.8.2 Ypsomed (Switzerland) Business Overview
  46. 8.8.3 Ypsomed (Switzerland) Injectable Drug Packaging Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Ypsomed (Switzerland) Injectable Drug Packaging Product Portfolio
  48. 8.8.5 Ypsomed (Switzerland) Recent Developments
  49. 8.9 B. Braun Melsungen (Germany)
  50. 8.9.1 B. Braun Melsungen (Germany) Company Information
  51. 8.9.2 B. Braun Melsungen (Germany) Business Overview
  52. 8.9.3 B. Braun Melsungen (Germany) Injectable Drug Packaging Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 B. Braun Melsungen (Germany) Injectable Drug Packaging Product Portfolio
  54. 8.9.5 B. Braun Melsungen (Germany) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Injectable Drug Packaging Value Chain Analysis
  2. 9.1.1 Injectable Drug Packaging Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Injectable Drug Packaging Sales Mode & Process
  6. 9.2 Injectable Drug Packaging Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Injectable Drug Packaging Distributors
  9. 9.2.3 Injectable Drug Packaging Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst